$26.00
0.91% yesterday
Nasdaq, Sep 03, 10:00 pm CET
ISIN
US90184D1000
Symbol
TWST

Twist Bioscience Corp. Stock price

$26.00
-4.21 13.94% 1M
-11.11 29.94% 6M
-20.47 44.05% YTD
-14.96 36.52% 1Y
-12.77 32.94% 3Y
-41.34 61.39% 5Y
+12.00 85.71% 10Y
+12.00 85.71% 20Y
Nasdaq, Closing price Wed, Sep 03 2025
-0.24 0.91%
ISIN
US90184D1000
Symbol
TWST
Industry

Key metrics

Basic
Market capitalization
$1.6b
Enterprise Value
$1.3b
Net debt
positive
Cash
$250.8m
Shares outstanding
60.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.4 | 4.1
EV/Sales
3.7 | 3.5
EV/FCF
negative
P/B
3.3
Financial Health
Equity Ratio
76.9%
Return on Equity
-44.2%
ROCE
-25.6%
ROIC
-38.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$362.3m | $382.7m
EBITDA
$-116.9m | $-50.3m
EBIT
$-142.4m | $-140.5m
Net Income
$-85.2m | $-84.3m
Free Cash Flow
$-68.7m
Growth (TTM | estimate)
Revenue
22.7% | 22.3%
EBITDA
23.7% | 65.2%
EBIT
23.7% | 20.1%
Net Income
61.3% | 59.6%
Free Cash Flow
8.3%
Margin (TTM | estimate)
Gross
49.2%
EBITDA
-32.3% | -13.1%
EBIT
-39.3%
Net
-23.5% | -22.0%
Free Cash Flow
-19.0%
More
EPS
$-1.4
FCF per Share
$-1.1
Short interest
20.6%
Employees
923
Rev per Employee
$340.0k
Show more

Is Twist Bioscience Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Twist Bioscience Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Twist Bioscience Corp. forecast:

14x Buy
78%
3x Hold
17%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a Twist Bioscience Corp. forecast:

Buy
78%
Hold
17%
Sell
6%

Financial data from Twist Bioscience Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
362 362
23% 23%
100%
- Direct Costs 184 184
5% 5%
51%
178 178
49% 49%
49%
- Selling and Administrative Expenses 236 236
11% 11%
65%
- Research and Development Expense 84 84
10% 10%
23%
-117 -117
24% 24%
-32%
- Depreciation and Amortization 26 26
23% 23%
7%
EBIT (Operating Income) EBIT -142 -142
24% 24%
-39%
Net Profit -85 -85
61% 61%
-24%

In millions USD.

Don't miss a Thing! We will send you all news about Twist Bioscience Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Twist Bioscience Corp. Stock News

Neutral
Business Wire
about 13 hours ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025 at 9:40 am Eastern Time in New York City. The company will also host one-on-one meeti...
Neutral
Business Wire
one day ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has collaborated with next generation therapeutics company, Synthetic Design Lab (SDL). “With our high throughput expertise, from novel binder discovery services to high throughput screening capabilities, we're able to support researchers...
Negative
Seeking Alpha
7 days ago
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery challenges and limited efficacy for cancer and infectious diseases, make mRNA-focused biotechs unattractive compared to broader biotech opportunities. Investors seeking exposure should consider 'pic...
More Twist Bioscience Corp. News

Company Profile

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.

Head office United States
CEO Emily Leproust
Employees 923
Founded 2013
Website www.twistbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today